To access the full text documents, please follow this link: http://hdl.handle.net/2445/111205

Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming
Romero, O. A.; Verdura, S.; Torres-Diz, M.; Gomez, A.; Moran, Sebastian; Esteller, Manel; Condom i Mundó, Enric; Villanueva Garatachea, Alberto; Sánchez Céspedes, Montserrat
Universitat de Barcelona
Components of the SWI/SNF chromatin remodeling complex, including BRG1 (also SMARCA4), are inactivated in cancer. Among other functions, SWI/SNF orchestrates the response to retinoid acid (RA) and glucocorticoids (GC) involving downregulation of MYC. The epigenetic drugs SAHA and azacytidine, as well as RA and GC, are currently being used to treat some malignancies but their therapeutic potential in lung cancer is not well established. Here we aimed to determine the possible therapeutic effects of azacytidine and SAHA (A/S) alone or in combination with GC plus RA (GC/RA) in lung cancers with either BRG1 inactivation or MYC amplification. In vitro, responses to GC/RA treatment were more effective in MYC-amplified cells. These effects were mediated by BRG1 and involved a reprogramming towards prodifferentiation gene expression signatures and downregulation of MYC. In MYC-amplified cells, administration of GC/RA enhanced the cell growth inhibitory effects of A/S which, in turn, accentuated the prodifferentiation features promoted by GC/RA. Finally, these treatments improved overall survival of mice orthotopically implanted with MYC-amplified, but not BRG1-mutant, cells and reduced tumor cell viability and proliferation. We propose that the combination of epigenetic treatments with retinoids and corticoids of MYC-driven lung tumors constitute a strategy for therapeutic intervention in this otherwise incurable disease.
-Retinoides
-Corticosteroides
-Epigènesi
-Oncogens
-Càncer de pulmó
-Retinoids
-Adrenocortical hormones
-Epigenesis
-Oncogenes
-Lung cancer
(c) Macmillan Publishers, 2016
Article
Article - Accepted version
Macmillan Publishers
         

Show full item record

Related documents

Other documents of the same author

Romero, Octavio A.; Setién, Fernando; John, Sam; Gimenez Xavier, Pol; Gómez López, Gonzalo; Pisano, David; Condom i Mundó, Enric; Villanueva Garatachea, Alberto; Hager, Gordon L.; Sánchez Céspedes, Montserrat
Romero, Octavio A.; Setién, Fernando; John, Sam; Gimenez Xavier, Pol; Gómez López, Gonzalo; Pisano, David; Condom i Mundó, Enric; Villanueva Garatachea, Alberto; Hager, Gordon L.; Sánchez Céspedes, Montserrat
Fernández, Agustín F.; Martín Subero, José Ignacio; Hidalgo, Manuel; Ferrer, Isidro (Ferrer Abizanda); Sánchez Céspedes, Montserrat; Villanueva Garatachea, Alberto; Carmona, F. Javier; Sanchez-Mut, Jose Vicente; Berdasco, María; Moreno Aguado, Víctor; Capellá, G. (Gabriel); Ballestar Tarín, Esteban; Pérez Jurado, Luis; Mora Graupera, Jaume; Puig i Sardà, Susana; Prat, Jaime; Badimón, Lina, 1953-; Esteller, Manel
Fernández, Agustín F.; Martín Subero, José Ignacio; Hidalgo, Manuel; Ferrer, Isidro (Ferrer Abizanda); Sánchez Céspedes, Montserrat; Villanueva Garatachea, Alberto; Carmona, F. Javier; Sanchez-Mut, Jose Vicente; Berdasco, María; Moreno Aguado, Víctor; Capellá, G. (Gabriel); Ballestar Tarín, Esteban; Pérez Jurado, Luis; Mora Graupera, Jaume; Puig i Sardà, Susana; Prat, Jaime; Badimón, Lina, 1953-; Esteller, Manel
Fernández, Agustín F.; Martín Subero, José Ignacio; Hidalgo, Manuel; Ferrer, Isidro (Ferrer Abizanda); Sánchez Céspedes, Montserrat; Villanueva Garatachea, Alberto; Carmona, F. Javier; Sanchez-Mut, Jose Vicente; Berdasco, María; Moreno Aguado, Víctor; Capellá, G. (Gabriel); Ballestar Tarín, Esteban; Pérez Jurado, Luis; Mora Graupera, Jaume; Puig i Sardà, Susana; Prat, Jaime; Badimón, Lina, 1953-; Esteller, Manel
 

Coordination

 

Supporters